# Care Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/care-labs

- Industry: Healthcare IT
- Headquarters: Montpellier, France
- Website: www.chequesante.com
- Total disclosed funding: $7.2M
- Latest round: Series C (Aug 24, 2017)
- Investors on record: 5

## About

Care Labs SAS develops digital health applications focused on enhancing user well-being and productivity. Their platform, chequesante.com, provides solutions for health management through innovative technology.Founded in 2014 in Montpellier, France, Care Labs SAS is dedicated to creating digital health solutions. The company has successfully executed 4 deals, with the most recent being a Series C round on June 1, 2022, where they raised EUR 5.199 mn, led by IXO Private Equity, bringing their total amount raised to EUR 5.199 mn and their current valuation to EUR 27.294 mn.Care Labs SAS offers a range of digital applications aimed at improving user health and productivity through their platform, chequesante.com. Their flagship product, the HONOR Health application, serves as a comprehensive health management tool, allowing users to monitor their physical activity, vital signs, and sports performance. Other applications include Ambiance Pluie for relaxation and sleep, and Motivated: Habit Tracker, which assists users in developing productive habits. Their services target a diverse clientele in Europe and North America, focusing on enhancing personal wellness through technology.In the most recent fiscal year of 2017, Care Labs SAS reported revenues of EUR -90,904 and an EBITDA of EUR -3,539,473. Their revenue model primarily revolves around direct-to-consumer transactions via app downloads, with opportunities for monetization through premium features or in-app purchases.Care Labs SAS is strategizing for future growth by designing new products and expanding into new regions. Specific upcoming products and their launch dates have not been detailed. The company intends to utilize the funding from their latest Series C round to support these initiatives, following the exit of IXO Private Equity from their stake in June 2022. The focus will be on enhancing their presence in existing markets while exploring potential entry into emerging regions.

## Funding rounds

- Series C, Aug 24, 2017, $6.1M — IXO Private Equity, Soridec
- Series B, Mar 24, 2015, $1.1M — Sofimac Partners, Soridec, JEREMIE LR, Sofilaro

## Investors

- Sofimac Partners (https://capitalatlas.ai/funds/sofimac-partners) — Series B
- Soridec — Series B, Series C
- JEREMIE LR — Series B
- Sofilaro (https://capitalatlas.ai/funds/sofilaro) — Series B
- IXO Private Equity (https://capitalatlas.ai/funds/ixo-private-equity) — Series C